- Home
- QTRX vs LEO Comparison
QTRX vs LEO Comparison
Compare QTRX & LEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QTRX
- LEO
- Stock Information
- Founded
- QTRX 2007
- LEO 1987
- Country
- QTRX United States
- LEO United States
- Employees
- QTRX N/A
- LEO N/A
- Industry
- QTRX Biotechnology: Laboratory Analytical Instruments
- LEO Trusts Except Educational Religious and Charitable
- Sector
- QTRX Industrials
- LEO Finance
- Exchange
- QTRX Nasdaq
- LEO Nasdaq
- Market Cap
- QTRX 492.0M
- LEO 394.9M
- IPO Year
- QTRX 2017
- LEO N/A
- Fundamental
- Price
- QTRX $15.09
- LEO $6.27
- Analyst Decision
- QTRX Strong Buy
- LEO
- Analyst Count
- QTRX 4
- LEO 0
- Target Price
- QTRX $23.00
- LEO N/A
- AVG Volume (30 Days)
- QTRX 372.5K
- LEO 200.2K
- Earning Date
- QTRX 11-12-2024
- LEO 01-01-0001
- Dividend Yield
- QTRX N/A
- LEO 4.01%
- EPS Growth
- QTRX N/A
- LEO N/A
- EPS
- QTRX N/A
- LEO 0.04
- Revenue
- QTRX $129,330,000.00
- LEO N/A
- Revenue This Year
- QTRX $13.56
- LEO N/A
- Revenue Next Year
- QTRX $16.61
- LEO N/A
- P/E Ratio
- QTRX N/A
- LEO $152.00
- Revenue Growth
- QTRX 15.52
- LEO N/A
- 52 Week Low
- QTRX $10.50
- LEO $4.98
- 52 Week High
- QTRX $29.70
- LEO $6.50
- Technical
- Relative Strength Index (RSI)
- QTRX 69.72
- LEO 41.97
- Support Level
- QTRX $12.80
- LEO $6.11
- Resistance Level
- QTRX $13.73
- LEO $6.37
- Average True Range (ATR)
- QTRX 0.69
- LEO 0.09
- MACD
- QTRX 0.31
- LEO -0.01
- Stochastic Oscillator
- QTRX 88.89
- LEO 38.82
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.
About LEO BNY Mellon Strategic Municipals Inc.
BNY Mellon Strategic Municipals, Inc. is a diversified closed-end management investment company. The fund's investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. Its products are Equity and Fixed Income Mutual Funds, Retail Money Market Funds, Government/Treasury Money Market Funds, Institutional Money Market Funds, and others.